Torskal (private company)

See something wrong or missing? Let us know
Offices:Paris
Business model:B2B

Torskal is a biotechnology startup frm France developing green nanotechnology - gold nanoparticles for cancer therapy.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 2.18M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Torskal

Name Criteria
Denmark Octarine Bio
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Pila Pharma
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France PEP-Therapy
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France Vaxxel
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Netherlands CimCure
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Mable
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Cinclus Pharma
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
Sweden iCellate
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
Sweden ITBMed
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
United Kingdom Causaly
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
Top